Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS
Neurology Research International · 2012 · 2012 · 1-7
DOI: 10.1155/2012/878030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Research International, 2012. Verfasst von Susanne Petri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hannover Medical School, Hannover, Germany. Die Arbeit wurde bisher 175-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIGMS NIH HHS, NCRR NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Nrf2 (nuclear erythroid 2-related factor 2) is a basic region leucine-zipper transcription factor which binds to the antioxidant response element (ARE) and thereby regulates the expression of a large battery of genes involved in the cellular antioxidant and anti-inflammatory defence as well as mitochondrial protection. As oxidative stress, inflammation and mitochondrial dysfunctions have been identified as important pathomechanisms in amyotrophic lateral sclerosis (ALS), this signaling cascade has gained interest both with respect to ALS pathogenesis and therapy. Nrf2 and Keap1 expressions are reduced in motor neurons in postmortem ALS tissue. Nrf2-activating compounds have shown therapeutic efficacy in the ALS mouse model and other neurodegenerative disease models. Alterations in Nrf2 and Keap1 expression and dysregulation of the Nrf2/ARE signalling program could contribute to the chronic motor neuron degeneration in ALS and other neurodegenerative diseases. Therefore, Nrf2 emerges as a key neuroprotective molecule in neurodegenerative diseases. Our recent studies strongly support that the Nrf2/ARE signalling pathway is an important mediator of neuroprotection and therefore represents a promising target for development of novel therapies against ALS, Parkinson’s disease (PD), Huntington’s disease (HD), and Alzheimer’s disease (AD).
Autor:innen und Institutionen
- Department of Neurology, Hannover Medical School, Hannover, Germany.
Förderung
- NIGMS NIH HHS
- NCRR NIH HHS
- National Institutes of Health
- National Center for Research Resources
- National Institute of General Medical Sciences
Zitieren
APA
Petri, S., Körner, S., & Kiaei, M. (2012). Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS. Neurology Research International, 2012, 1-7. https://doi.org/10.1155/2012/878030
Vancouver
Petri S, Körner S, Kiaei M. Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS. Neurology Research International. 2012;2012:1-7. doi:10.1155/2012/878030
BibTeX
@article{Petri2012,
author = {Petri, Susanne and Körner, Sonja and Kiaei, Mahmoud},
title = {Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS},
journal = {Neurology Research International},
year = {2012},
volume = {2012},
pages = {1--7},
doi = {10.1155/2012/878030}
}
EUVIMED